Table 2.
(A) CTC Count in 2 mL PB Blood | |||||||||||||
NAC (−) | NAC (+) | ||||||||||||
Disease Stages | No. of Cases | Range | Mean | Median | SD | Mode | Disease Stages | No. of Cases | Range | Mean | Median | SD | Mode |
0 | 1 | N/A | 3 | N/A | N/A | N/A | 0 | 0 | N/A | N/A | N/A | N/A | N/A |
I | 40 | 0–13 | 1.95 | 1 | 2.94 | 0 | I | 4 | 0–5 | 1.5 | 0.5 | 2.06 | 0 |
II | 30 | 0–9 | 2.17 | 2 | 2.27 | 0 | II | 21 | 0–22 | 2.48 | 1 | 4.61 | 0 |
III | 1 | N/A | 3 | N/A | N/A | N/A | III | 50 | 0–24 | 5.28 | 3 | 6.22 | 0 |
IV | 1 | N/A | 4 | N/A | N/A | N/A | IV | 15 | 0–16 | 4.87 | 4 | 4.51 | 4 |
(B) CTC Count in 2 mL MVB Blood | |||||||||||||
NAC (−) | NAC (+) | ||||||||||||
Disease Stages | No. of Cases | Range | Mean | Median | SD | Mode | Disease Stages | No. of Cases | Range | Mean | Median | SD | Mode |
0 | 1 | N/A | 0 | N/A | N/A | N/A | 0 | 0 | N/A | N/A | N/A | N/A | N/A |
I | 35 | 0–24 | 4.31 | 2 | 5.76 | 0 | I | 2 | 6–7 | 6.5 | 6.5 | 0.5 | N/A |
II | 25 | 6–7 | 3.16 | 2 | 4.09 | 0 | II | 18 | 0–8 | 2.72 | 2 | 2.45 | 2 |
III | 2 | 0–17 | 6.5 | 6.5 | 0.5 | N/A | III | 45 | 0–35 | 4.44 | 2 | 7.69 | 0 |
IV | 1 | N/A | 28 | N/A | N/A | N/A | IV | 12 | 0–24 | 8.08 | 5 | 7.16 | 5 |
NAC—neoadjuvant chemotherapy; SEM—standard error of mean; N/A—not available.